Toxoplasma gondii: Protective immunity against toxoplasmosis with recombinant actin depolymerizing factor protein in BALB/c mice

Experimental Parasitology

Volumn 130, Issue 3, 2012, Pages 218-222

  Huang, Xiangsheng ^a   Li, Jianhua ^a   Zhang, Guocai ^a   Gong, Pengtao ^a   Yang, Ju ^a   Zhang, Xichen ^a  

^a JILIN UNIVERSITY   (China)

Author keywords

Actin depolymerizing factor; BALB c mice; Recombinant protein; Toxoplasma gondii

Indexed keywords

ACTIN DEPOLYMERIZING FACTOR; IMMUNOGLOBULIN G ANTIBODY; RECOMBINANT ACTIN DEPOLYMERIZING FACTOR SUBUNIT VACCINE; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; BRAIN CYST; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DRUG EFFICACY; ESCHERICHIA COLI; IMMUNITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL TIME; TACHYZOITE; TOXOPLASMA GONDII; TOXOPLASMOSIS; VACCINATION;

ANIMALS; ANTIBODIES, PROTOZOAN; BLOTTING, WESTERN; BRAIN; CD4-CD8 RATIO; DESTRIN; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; IMMUNOGLOBULIN G; MALE; MICE; MICE, INBRED BALB C; PROTOZOAN VACCINES; RANDOM ALLOCATION; RECOMBINANT PROTEINS; TOXOPLASMA; TOXOPLASMOSIS, ANIMAL; VACCINES, SUBUNIT;

ESCHERICHIA COLI; MUS; TOXOPLASMA GONDII;

EID: 84862822520     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2012.01.001     Document Type: Article

References (27)

1. Allen M.L., Dobrowolski J.M., Muller H., Sibley L.D., Mansour T.E. Cloning and characterization of actin depolymerizing factor from Toxoplasma gondii. Mol. Biochem. Parasitol. 1997, 88:43-52.
2. Beghetto E., Nielsen H.V., Del Porto P., Buffolano W., Guglietta S., Felici F., Petersen E., Gargano N. A combination of antigenic regions of Toxoplasma gondii microneme proteins induces protective immunity against oral infection with parasite cysts. J. Infect. Dis. 2005, 191:637-645.
3. Bhopale G.M. Development of a vaccine for toxoplasmosis: current status. Microbes Infect. 2003, 5:457-462.
4. Black M.W., Boothroyd J.C. Lytic cycle of Toxoplasma gondii. Microbiol. Mol. Biol. Rev. 2000, 64:607-623.
5. Bülow R., Boothroyd J.C. Protection of mice from fatal Toxoplasma gondii infection by immunization with p30 antigen in liposomes. J. Immunol. 1991, 147:3496-3500.
6. Cuppari A.F., Sanchez V., Ledesma B., Frank F.M., Goldman A., Angel S.O., Martin V. Toxoplasma gondii protease inhibitor-1 (TgPI-1) is a novel vaccine candidate against toxoplasmosis. Vaccine 2008, 26:5040-5045.
7. Denkers E.Y., Gazzinelli R.T. Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection. Clin. Microbiol. Rev. 1998, 11:569-588.
8. Dobrowolski J.M., Sibley L.D. The role of the cytoskeleton in host cell invasion by Toxoplasma gondii. Behring Inst Mitt 1997, 99:90-96.
9. Dubey J.P. Status of toxoplasmosis in sheep and goats in the United States. Am. Vet. Med. Assoc. 1990, 196:259-262.
10. Dziadek B., Gatkowska J., Brzostek A., Dziadek J., Dzitko K., Dlugonska H. Toxoplasma gondii: the immunogenic and protective efficacy of recombinant ROP2 and ROP4 rhoptry proteins in murine experimental toxoplasmosis. Exp. Parasitol. 2009, 123:81-89.
11. Fowler R.E., Margos G., Mitchell G.H. The cytoskeleton and motility in apicomplexan invasion. Adv. Parasitol. 2004, 56:213-263.
12. Golkar M., Shokrgozar M.A., Rafati S., Musset K., Assmar M., Sadaie R., Cesbron-Delauw M.F., Mercier C. Evaluation of protective effect of recombinant dense granule antigens GRA2 and GRA6 formulated in monophosphoryl lipid A (MPL) adjuvant against Toxoplasma chronic infection in mice. Vaccine 2007, 25:4301-4311.
13. Haumont M., Delhaye L., Garcia L., Jurado M., Mazzu P., Daminet V., Verlant V., Bollen A., Biemans R., Jacquet A. Protective immunity against congenital toxoplasmosis with recombinant SAG1 protein in a guinea pig model. Infect. Immun. 2000, 68:4948-4953.
14. Hu K., Johnson J., Florens L., Fraunholz M., Suravajjala S., DiLullo C., Yates J., Roos D.S., Murray J.M. Cytoskeletal components of an invasion machine the apical complex of Toxoplasma gondii. PLoS Pathog. 2006, 2:e13.
15. Innes E.A., Bartley P.M., Maley S., Katzer F., Buxton D. Veterinary vaccines against Toxoplasma gondii. Memórias do Instituto Oswaldo Cruz 2009, 104:246-251.
16. Ismael A.B., Sekkai D., Collin C., Bout D., Mévélec M.N. The MIC3 gene of Toxoplasma gondii is a novel potent vaccine candidate against toxoplasmosis. Infect. Immun. 2003, 71:6222-6228.
17. Jenkins M.C. Advances and prospects for subunit vaccines against protozoa of veterinary importance. Vet. Parasitol. 2001, 101:291-310.
18. King C.A. Cell motility of sporozoan protozoa. Parasitol. Today 1988, 11:315-318.
19. Letscher-Bru V., Villard O., Risse B., Zauke M., Klein J.P., Kien T.T. Protective effect of vaccination with a combination of recombinant surface antigen 1 and interleukin-12 against toxoplasmosis in mice. Infect. Immun. 1998, 66:4503-4506.
20. Martin V., Supanitsky A., Echeverria P.C., Litwin S., Tanos T., De Roodt A.R., Guarnera E.A., Angel S.O. Recombinant GRA4 or ROP2 protein combined with alum or the gra4 gene provides partial protection in chronic murine models of toxoplasmosis. Clin. Diagn. Lab. Immunol. 2004, 11:704-710.
21. Mateus-Pinilla N.E., Dubey J.P., Choromanski L., Weigel R.M. A field trial of the effectiveness of a feline Toxoplasma gondii vaccine in reducing T. gondii exposure for swine. J. Parasitol. 1999, 85:855-860.
22. Mehta S., Sibley L.D. Toxoplasma gondii actin depolymerizing factor acts primarily to sequester G-actin. J. Biol. Chem. 2010, 255(9):6835-6847.
23. Morrissette N.S., Sibley L.D. Cytoskeleton of apicomplexan parasites. Microbiol. Mol. Biol. Rev. 2002, 66:21-38.
24. Parmley S., Slifer T., Araujo F. Protective effects of immunization with a recombinant cyst antigen in mouse models of infection with Toxoplasma gondii tissue cysts. J. Infect. Dis. 2002, 185(Suppl 1):S90-95.
25. Saavedra R., Becerril M.A., Dubeaux C.R., Lippens M.D., Herion V.P., Bollen A. Epitopes recognized by human T lymphocytes in the RoP2 protein antigen of Toxoplasma gondii. Infect. Immun. 1996, 64:3858-3862.
26. Sibley L.D. Intracellular parasite invasion strategies. Science 2004, 304:248-253.
27. Wang H., Liu Q., Liu K., Zhong W., Gao S., Jiang L., An N. Immune response induced by recombinant Mycobacterium bovis BCG expressing ROP2 gene of Toxoplasma gondii. Parasitol. Int. 2007, 56:263-268.